0001183740-20-000214.txt : 20201006 0001183740-20-000214.hdr.sgml : 20201006 20201006152320 ACCESSION NUMBER: 0001183740-20-000214 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201006 DATE AS OF CHANGE: 20201006 EFFECTIVENESS DATE: 20201006 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SERNOVA CORP. CENTRAL INDEX KEY: 0001491434 IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-377234 FILM NUMBER: 201226622 BUSINESS ADDRESS: STREET 1: 120-700 COLLIP CIRCLE CITY: LONDON STATE: A6 ZIP: N6G 4X8 BUSINESS PHONE: 519-858-5126 MAIL ADDRESS: STREET 1: 120-700 COLLIP CIRCLE CITY: LONDON STATE: A6 ZIP: N6G 4X8 D 1 primary_doc.xml X0708 D LIVE 0001491434 SERNOVA CORP. 700 Collip Circle, Suite 114 LONDON A6 ONTARIO, CANADA N6G 4X8 519-858-5126 CANADA (FEDERAL LEVEL) None None Corporation true Philip Toleikis 700 Collip Circle, Suite 114 London A6 ONTARIO, CANADA N6G 4X8 Executive Officer Director David Swetlow 700 Collip Circle, Suite 114 London A6 ONTARIO, CANADA N6G 4X8 Executive Officer Frank A. Holler 700 Collip Circle, Suite 114 London A6 ONTARIO, CANADA N6G 4X8 Director Jeffrey A. Bacha 700 Collip Circle, Suite 114 London A6 ONTARIO, CANADA N6G 4X8 Director James Parsons 700 Collip Circle, Suite 114 London A6 ONTARIO, CANADA N6G 4X8 Director Deborah M. Brown 700 Collip Circle, Suite 114 London A6 ONTARIO, CANADA N6G 4X8 Director Biotechnology Decline to Disclose 06b false 2020-09-22 true true true true true Units comprised of one common share and one common share purchase warrant. Each warrant is exercisable into a common share at C$0.35 per share for 24 months, subject to acceleration. false 0 41509 19158 22351 Total Offering Amount represents price of Units (85000 x C$0.30(US$0.23)) plus exercise price of underlying warrants (85000 x C$0.35(US$0.26)). No guarantee that warrants, expiring 9/22/2022, will be exercised. Exchange rate of US$1: C$1.3310 on 9/22/2020 false 1 0 0 0 false SERNOVA CORP. /s/ Philip Toleikis Dr. Philip Toleikis President and CEO 2020-10-06